Surveillance of Coronavirus Disease 2019 (COVID-19) Testing in Clinical Laboratories in Korea
Hee-Jae HUH; Ki-Ho HONG; Taek-Soo KIM; Sang-Hoon SONG; Kyoung-Ho ROH; Hyukmin LEE; Gye-Cheol KWON.
Annals of Laboratory Medicine
; : 225-229, 2021.
Artículo en Inglés | WPRIM | ID: wpr-874170
Documentos relacionados
Surveillance of Coronavirus Disease 2019 (COVID-19) Testing in Clinical Laboratories in Korea.
[Comparative Analysis of the Effect of Different Nucleic Acid Extraction Methods on SARS-CoV-2 Quantitative Real-Time Reverse Transcription Polymerase Chain Reaction Results].
Comparing Nasopharyngeal Swab and Early Morning Saliva for the Identification of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Comparative study of SmartAmp assay and reverse transcription-polymerase chain reaction by saliva specimen for the diagnosing COVID-19.
The Life of SARS-CoV-2 Inside Cells: Replication-Transcription Complex Assembly and Function.
First Reported Nosocomial Outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 in a Pediatric Dialysis Unit.
The first detection of SARS-CoV-2 RNA in urban wastewater in Giza, Egypt.
Epidemiologic Characteristics Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen-Based Test Results, Real-Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) Cycle Threshold Values, Subgenomic RNA, and Viral Culture Results From University Testing.
External Quality Assessment for Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detection in Chongqing, China.
[Evaluation of the Diagnostic Performance of SARS-CoV-2 Rapid Antigen Tests in COVID-19 Patients].